Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors.
Acta Derm Venereol
; 104: adv34206, 2024 Sep 09.
Article
in En
| MEDLINE
| ID: mdl-39248291
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Uveitis
/
Severity of Illness Index
/
Ustekinumab
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Acta Derm Venereol
Year:
2024
Document type:
Article